Literature DB >> 12025235

Biology of natural killer cells in cancer and infection.

Jeffrey S Miller1.   

Abstract

NK cells are the important cells of the immune system derived from stem cells in the marrow. Their physiology is tightly regulated to control proliferation, cytotoxicity and cytokine production. In cancer, NK cells may be abnormal due to the cancer itself or possibly related to its therapy. The finding of class I recognizing inhibitory receptors may play a role in stem cell transplant rejection, immune surveillance and cancer immunotherapy. NK cells should no longer be thought of as direct cytotoxic killers alone, as they clearly play a critical role in cytokine production which may be important to control cancer and infection. Understanding NK cell function and homing may lead to novel therapeutic strategies for the treatment of human disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12025235     DOI: 10.1081/cnv-120001185

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  24 in total

1.  The mature activating natural killer cell immunologic synapse is formed in distinct stages.

Authors:  Jordan S Orange; K Eliza Harris; Milena M Andzelm; Markus M Valter; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

2.  Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.

Authors:  Isabel Barao; Maite Alvarez; Erik Ames; Mark T Orr; Heather E Stefanski; Bruce R Blazar; Lewis L Lanier; Stephen K Anderson; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2011-04-15       Impact factor: 22.113

3.  Lung natural killer cells in mice: phenotype and response to respiratory infection.

Authors:  Jian Wang; Fengqi Li; Meijuan Zheng; Rui Sun; Haiming Wei; Zhigang Tian
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

4.  Licensing delineates helper and effector NK cell subsets during viral infection.

Authors:  Anthony E Zamora; Ethan G Aguilar; Can M Sungur; Lam T Khuat; Cordelia Dunai; G Raymond Lochhead; Juan Du; Claire Pomeroy; Bruce R Blazar; Dan L Longo; Jeffrey M Venstrom; Nicole Baumgarth; William J Murphy
Journal:  JCI Insight       Date:  2017-05-18

5.  Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.

Authors:  Kai Sun; Maite Alvarez; Erik Ames; Isabel Barao; Mingyi Chen; Dan L Longo; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

Review 6.  Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.

Authors:  William Reed; Stephen J Noga; Adrian P Gee; Cliona M Rooney; John E Wagner; Jeffrey McCullough; David H McKenna; Theresa L Whiteside; Albert D Donnenberg; Acacia K Baker; Robert W Lindblad; Elizabeth L Wagner; Traci Heath Mondoro
Journal:  Transfusion       Date:  2008-12-23       Impact factor: 3.157

7.  Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.

Authors:  Can M Sungur; Yajarayma J Tang-Feldman; Erik Ames; Maite Alvarez; Mingyi Chen; Dan L Longo; Claire Pomeroy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

8.  Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.

Authors:  Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

9.  Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma.

Authors:  Cristina M Tato; Nicola Mason; David Artis; Sagi Shapira; Jorge C Caamano; Jay H Bream; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2006-02-15       Impact factor: 4.823

10.  Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Authors:  Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Sarah Cooley; Harriet Noreen; Juliet N Barker; Todd DeFor; Michael R Verneris; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.